ABSTRACT
Objectives To know and explore from convalescent plasma donator’s voices the experience in the blood donation process at a Peruvian social security hospital.
Methods Qualitative study with a phenomenological design. The investigation was carried out in 01 hospitals of the social security of Peru. Semi-structured interviews were carried out.
Results Eleven donors of convalescent plasma were interviewed. The main motivations for donating were being able to contribute to national research and supporting patients affected by COVID-19. Fears focus on the possible risk of contagion within the hospital. Donors emphasised the attention and support of health personnel alongside the donation procedure. The main expectations and suggestions point towards greater dissemination of donation campaigns with special emphasis on safety. Likewise, an improvement in the time of the donation procedure (from enrolment to the extraction of convalescent plasma), and the implementation of friendly spaces to encourage future blood donation campaigns were highlighted.
Conclusions The experience of the convalescent plasma donors was positive. However, improvements must be made in terms of processes and infrastructure to ensure future successful blood donation campaigns.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Instituto de Evaluacion de Tecnologias en Salud e Investigacion - IETSI, EsSalud, Peru. Likewise, this is an ancillary study to a clinical trial partially funded by the National Council of Science, Technology and Technological Innovation, CONCYTEC, through the National Fund for Scientific, Technological Development and Technological Innovation, FONDECYT, subvention N 068-2020-FONDECYT by Legislative Decree 1473.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the EsSalud Institutional Review Board of COVID studies on December 19, 2020.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of interest: The authors declare that they have no conflicts of interest. Some authors were working in EsSalud at the time the project was carried out and the manuscript was written.
Funding: This study was funded by the Instituto de Evaluacion de Tecnologias en Salud e Investigacion - IETSI, EsSalud, Peru. Likewise, this is an ancillary study to a clinical trial partially funded by the National Council of Science, Technology and Technological Innovation 471 (CONCYTEC) through the National Fund for Scientific, Technological Development and 472 Technological Innovation (FONDECYT), subvention (Nº068-2020-FONDECYT) by Legislative Decree Nº 1473.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
